专利检索 ap:("Bayer Schering Pharma AG") AND inv:"BÄRFACKER, Lars" 第 1 页

1.

发明公开
3-CYANO-5-THIAZAHETEROARYL-DIHYDROPYRIDINE UND IHRE VERWENDUNG ZUR BEHANDLUNG KARDIOVASKULÄRER ERKRANKUNGEN 有权
标题翻译： 3-氰基-5- THIAZAHETEROARYL二氢吡啶和心血管疾病的治疗用途

公开(公告)号：EP2086969A1

公开(公告)日：2009-08-12

申请号：EP07802224.1

申请日：2007-09-08

申请人： Bayer Schering Pharma AG

发明人： BÄRFACKER, Lars , KOLKHOF, Peter , SCHLEMMER, Karl-Heinz , GROSSER, Rolf , NITSCHE, Adam

IPC分类号： C07D417/04 , C07D417/14 , A61K31/4427 , A61P9/00

CPC分类号： C07D417/04 , C07D417/14

摘要： The present application relates to a novel, aryl-substituted 3-Cyano-5-thiazolyl and 3-Cyano-5-thiadiazolyl-1,4-dihydropyridine, a method for the production thereof, the use thereof for the treatment and/or prophylaxis of illnesses, as well as the use thereof for the production of medications for the treatment and/or prophylaxis of illnesses, particularly cardiovascular diseases.